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INTRODUCTION
Some of the most widespread drugs are those, 
which contain in their structures a heterocyclic frag-
ment (1-3). This could be explained by the fact that 
heterocycle containing compounds play an impor-
tant role in the metabolic processes. Thus, NAD and 
NADP (coenzymes of dehydrogenases) are pyridine 
derivatives, vitamin B
6
, which is rather important for 
amino acid metabolism is a pyrimidine derivative, 
and purine and xanthine heterocycles are part of the 
nucleotides (4, 5).
So chemical modification of well-known natu-
ral substances is one of the most promising ways for 
ABSTRACT
In this work, we have described the method of 3-benzyl-8-methylxanthinyl-7-acetohydrazide synthesis and 
studied its reaction with different aldehydes and ketones in acidic medium. As result, we obtained a series of 
novel ylidenhydrazides of 3-benzyl-8-methylxanthinyl-7-acetic acid. The structure of the synthesized sub-
stances was proved by IR and NMR spectra and elemental analysis and their individuality was confirmed by 
thin-layer chromatography.
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synthesis of novel less toxic biological active com-
pounds, which are also potential medicines. 
Xanthine derivatives are handy objects for 
pharmaceutical research. They are low-toxicity natu-
ral compounds with a wide spectrum of pronounced 
pharmacological properties (antioxidant, diuretic, 
antibacterial, anti-inflammatory, etc.) and high vari-
ability of chemical modification (6-8). At the same 
time, the hydrazine group is one of the most chem-
ically active functional groups, which easily partici-
pates in reactions of nucleophilic addition (9, 10) and 
insertion of such functional fragment to the struc-
ture of xanthine molecule could have some positive 
effect on its synthetic potential (9-11).
In this article we have described the method 
of synthesis of hydrazide of 3-beznyl-8-methylxan-
thinyl-7-acetic acid and its N-substituted derivatives 
and have studied their physicochemical properties.
MATERIALS AND METHODS
Melting points were determined using the cap-
illary method on DMP (M). 1Н NMR-spectra were 
recorded by Varian Mercury VX-200 device (com-
pany «Varian» – USA), solvent – (DMSO-d6), in-
40
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ternal standard – ТМS. Chemical shifts are report-
ed in ppm (parts per million) values. Infrared (IR) 
spectra were measured on a Bruker Alpha instru-
ment using a potassium bromide (KBr) disk, scan-
ning from 400 to 4000 cm-1. Elemental analysis of 
obtained compounds was produced on device Ele-
mentar Vario L cube. Analytical thin-layer chroma-
tography (TLC) was carried out on precoated plates, 
and spots were visualized with ultraviolet (UV) light. 
Systems, that were used for chromatography: «ace-
tone-propanol-2» 5:2 ratio. All chemicals or reagents 
were purchased from standard commercial suppliers 
and treated with standard methods before use.
Propyl 3-benzyl-8-methylxanthinyl-7-acetate 3 




To heated suspension of 0.01 mmol ester 3 in 
30 ml of propanol, 5 ml of hydrazine hydrate were 
added. The solution that formed was refluxed for 
30 min. After cooling, a white solid was precipitat-
ed. It was filtered out, washed by water and dried at 
80-85 °С.
Yield 89.1 %. M.p. >300 °С. R
f









Found, %: C, 55.17; H, 4.61; N, 25.30. Calculated, %: 
C, 54.87; H, 4.91; N, 25.60. IR-spectrum (ν, sm-1): 3298 
(NH), 3140 (NH), 3002 (CH
arom
), 1710 (C=O), 1675 
(C=O), 1640 (C=N), 1592 (C=C). 1H NMR-spectrum 
(δ-scale, ppm., solvent DMSO-d
6
): 11.12 (1H, s, N1H), 
9.36 (1H, s, NH), 7.46-7.12 (5H, m, CH
arom
), 5.12 (2H, 
s, N3-CH
2
), 4.98 (2H, s, N7-CH
2
), 4.52 (2H, ws, NH
2
), 
2.35 (3H, s, C8-CH
3
).
General procedure for benzylidenhydrazides of 
-benzyl-8-methylxanthinyl-7-acetic acid synthesis 
5a-l
Method A. To the solution of 3.28 g (0.01 mole) 
hydrazide 4 in 15 ml 50 % acetic acid, 0.011 mole of al-
dehyde was added. The mixture was refluxed for 15-
30 min. After cooling, a solid was precipitated. It was 
filtered out, washed by water and dried at 80-85 °С.
Method B. To the solution (heated up to 50 °С) 
of 3.28 g (0.01 mole) hydrazide 4 in 70 ml aqueous di-
oxane (1:1), 3 ml of glacial acetic acid and 0.011 mole 
of aldehyde were added. The mixture was refluxed 
for 15-20 min. After cooling, a solid was precipitat-
ed. The solid was filtered out, washed by water and 
dried at 80-85 °С.
Ylidenhydrazides 5p-s were synthesized by the 
same procedure. Ylidenhydrazides 5m-o were ob-
tained by method B, but the mixture of reagents was 
not refluxed. It was heated at 80 °С for 30 min.
Benzylidenhydrazide of -benzyl-8-methylxan-
thinyl-7-acetic acid (5a)
Yield 96.7  %. M.p. >300 °С. R
f









. Found, %: C, 63.15; H, 5.14; N, 20.48. 
Calculated, %: C, 63.45; H, 4.84; N, 20.18. IR-spec-
trum (ν, sm-1): 3290 (NH), 3120 (NH), 3040 (CH
arom
), 
1710 (C=O), 1680 (C=O), 1640 (C=N), 1592 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.78 (1H, s, CONH), 11.14 (1H, s, N1H), 8.05 (1H, 
s, N=CH), 7.74-7.56 (2H, t, CH
arom
), 7.51-7.16 (8H, m, 
CH
arom
), 5.48 (2H, s, N7-CH
2
), 5.06 (2H, s, N3-CH
2
), 





Yield 81.6  %. M.p. 289-291 °С. R
f









. Found, %: C, 63.87; H, 5.45; N, 19.82. 
Calculated, %: C, 64.17; H, 5.15; N, 19.52. IR-spec-
trum (ν, sm-1): 3300 (NH), 3120 (NH), 3010 (CH
arom
), 
1722 (C=O), 1681 (C=O), 1620 (C=N), 1597 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.72 (1H, s, CONH), 11.17 (1H, s, N1H), 7.96 (1H, 
s, N=CH), 7.62-7.51 (2H, t, CH
arom
), 7.34-7.12 (7H, m, 
CH
arom
), 5.46 (2H, s, N7-CH
2
), 5.09 (2H, s, N3-CH
2
), 





Yield 85.2 %. M.p. >300 °С. R
f









. Found, %: C, 58.30; H, 4.55; N, 18.34. Calculat-
ed, %: C, 58.60; H, 4.25; N, 18.64. IR-spectrum (ν, sm-
1): 3280 (NH), 3120 (NH), 3040 (CH
arom
), 1720 (C=O), 
1681 (C=O), 1650 (C=N), 1570 (C=C). 1H NMR-spec-
trum (δ-scale, ppm., solvent DMSO-d
6
): 11.82 (1H, s, 
CONH), 11.12 (1H, s, N1H), 8.69 (1H, s, N=CH), 7.89-
7.81 (1H, d, CH
arom
), 7.77-7.61 (1H, t, CH
arom
), 7.54-
7.38 (2H, m, CH
arom





), 5.04 (2H, s, N3-CH
2






Yield 84.3 %. M.p. >300 °С. R
f









. Found, %: C, 53.05; H, 4.17; N, 16.67. Calculat-
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ed, %: C, 53.35; H, 3.87; N, 16.63. IR-spectrum (ν, sm-
1): 3250 (NH), 3160 (NH), 3061 (CH
arom
), 1710 (C=O), 
1680 (C=O), 1630 (C=N), 1570 (C=C). 1H NMR-spec-
trum (δ-scale, ppm., solvent DMSO-d
6
): 11.86 (1H, 
s, CONH), 11.18 (1H, s, N1H), 8.62 (1H, s, N=CH), 
7.82-7.51 (7H, m, CH
arom
), 7.32-7.14 (2H, m, CH
arom
), 
5.49 (2H, s, N7-CH
2
), 4.99 (2H, s, N3-CH
2






Yield 90.5 %. M.p. >300 °С. R
f









. Found, %: C, 61.12; H, 4.11; N, 19.65. Calcu-
lated, %: C, 60.82; H, 4.41; N, 19.35. IR-spectrum (ν, 
sm-1): 3317 (NH), 3139 (NH), 3036 (CH
arom
), 1729 
(C=O), 1683 (C=O), 1667 (C=N), 1590 (C=C). 1H 
NMR-spectrum (δ-scale, ppm., solvent DMSO-d
6
): 
11.79 (1H, s, CONH), 11.15 (1H, s, N1H), 7.99 (1H, s, 
N=CH), 7.84-7.62 (2H, m, CH
arom
), 7.39-7.18 (7H, m, 
CH
arom
), 5.46 (2H, s, N7-CH
2
), 5.03 (2H, s, N3-CH
2
), 





Yield 92.1 %. M.p. >300 °С. R
f










. Found, %: C, 58.71; H, 4.31; N, 18.28. Calculat-
ed, %: C, 58.41; H, 4.01; N, 18.58. IR-spectrum (ν, sm-
1): 3290 (NH), 3150 (NH), 3030 (CH
arom
), 1717 (C=O), 
1698 (C=O), 1669 (C=N), 1584 (C=C). 1H NMR-spec-
trum (δ-scale, ppm., solvent DMSO-d
6
): 11.86 (1H, s, 
CONH), 11.15 (1H, s, N1H), 7.97 (1H, s, N=CH), 7.89-
7.72 (1H, m, CH
arom
), 7.61-7.39 (2H, m, CH
arom
), 7.34-
7.12 (5H, m, CH
arom
), 5.44 (2H, s, N7-CH
2
), 5.06 (2H, 
s, N3-CH
2





Yield 89.7  %. M.p. 283-285 °С. R
f









. Found, %: C, 63.03; H, 5.78; N, 21.74. 
Calculated, %: C, 62.73; H, 5.48; N, 21.55. IR-spec-
trum (ν, sm-1): 3290 (NH), 3130 (NH), 3047 (CH
arom
), 
1719 (C=O), 1700 (C=O), 1642 (C=N), 1576 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.49 (1H, s, CONH), 11.10 (1H, s, N1H), 7.85 (1H, 
s, N=CH), 7.54-7.46 (2H, d, CH
arom
), 7.38-7.19 (5H, m, 
CH
arom
), 6.79-6.61 (2H, d, CH
arom
), 5.45 (2H, s, N7-
CH
2
), 5.07 (2H, s, N3-CH
2








Yield 86.3  %. M.p. >300 °С. R
f









. Found, %: C, 60.80; H, 4.36; N, 19.13. 
Calculated, %: C, 61.10; H, 4.66; N, 19.43. IR-spec-
trum (ν, sm-1): 3300 (NH), 3140 (NH), 3020 (CH
arom
), 
1725 (C=O), 1689 (C=O), 1640 (C=N), 1590 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.59 (1H, s, CONH), 11.11 (1H, s, N1H), 9.89 (1H, 
s, OH), 7.88 (1H, s, N=CH), 7.54-7.48 (2H, d, CH
arom
), 
7.34-7.19 (5H, m, CH
arom
), 6.85-6.72 (2H, d, CH
arom
), 
5.45 (2H, s, N7-CH
2
), 5.05 (2H, s, N3-CH
2






Yield 95.5  %. M.p. >300 °С. R
f









. Found, %: C, 61.57; H, 5.27; N, 19.12. 
Calculated, %: C, 61.87; H, 4.97; N, 18.82. IR-spec-
trum (ν, sm-1): 3280 (NH), 3160 (NH), 3030 (CH
arom
), 
1700 (C=O), 1679 (C=O), 1660 (C=N), 1602 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.64 (1H, s, CONH), 11.13 (1H, s, N1H), 7.95 (1H, 
s, N=CH), 7.68-7.55 (2H, d, CH
arom
), 7.49-7.14 (5H, m, 
CH
arom
), 7.07-6.86 (2H, d, CH
arom
), 5.46 (2H, s, N7-
CH
2
), 5.08 (2H, s, N3-CH
2








Yield 91.7 %. M.p. >300 °С. R
f









Found, %: C, 57.56; H, 3.85; N, 20.95. Calculated, %: 
C, 57.26; H, 4.15; N, 21.25. IR-spectrum (ν, sm-1): 3260 
(NH), 3130 (NH), 2997 (CH
arom
), 1703 (C=O), 1689 
(C=O), 1642 (C=N), 1583 (C=C). 1H NMR-spec-
trum (δ-scale, ppm., solvent DMSO-d
6
): 12.05 (1H, s, 
CONH), 11.14 (1H, s, N1H), 8.12 (1H, s, N=CH), 8.39-
8.16 (2H, d, CH
arom
), 8.08-7.86 (2H, d, CH
arom
), 7.39-
7.11 (5H, m, CH
arom
), 5.61 (2H, s, N7-CH
2
), 5.09 (2H, 
s, N3-CH
2





Yield 86.8  %. M.p. 293-294 °С. R
f









. Found, %: C, 57.56; H, 4.45; N, 21.55. 
Calculated, %: C, 57.26; H, 4.15; N, 21.25. IR-spec-
trum (ν, sm-1): 3340 (NH), 3120 (NH), 3030 (CH
arom
), 
1700 (C=O), 1680 (C=O), 1650 (C=N), 1590 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 12.01 (1H, s, CONH), 11.19 (1H, s, N1H), 8.51 (1H, 
s, N=CH), 8.36-8.08 (3H, m, CH
arom
), 7.75-7.61 (1H, 
42
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t, CH
arom
), 7.41-7.15 (5H, m, CH
arom
), 5.54 (2H, s, N7-
CH
2
), 5.04 (2H, s, N3-CH
2





Yield 80.1  %. M.p. 274-276 °С. R
f









. Found, %: C, 60.03; H, 4.49; N, 18.47. 
Calculated, %: C, 59.73; H, 4.79; N, 18.17. IR-spec-
trum (ν, sm-1): 3270 (NH), 3167 (NH), 3101 (CH
arom
), 
1712 (C=O), 1677 (C=O), 1650 (C=N), 1590 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.59 (1H, s, CONH), 11.15 (1H, s, N1H), 9.51 (1H, 
s, OH), 7.89 (1H, s, N=CH), 7.34-7.19 (6H, m, CH
a-
rom
), 7.14-7.01 (1H, t, CH
arom
), 6.82-6.71 (1H, d, CH
a-
rom
), 5.46 (2H, s, N7-CH
2










Yield 89.4  %. M.p. 290-292 °С. R
f









. Found, %: C, 59.52; H, 4.32; N, 19.23. 
Calculated, %: C, 59.82; H, 4.02; N, 19.53. IR-spec-
trum (ν, sm-1): 3290 (NH), 3150 (NH), 3020 (CH
arom
), 
1700 (C=O), 1678 (C=O), 1640 (C=N), 1574 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 12.08 (1H, s, CONH), 11.15 (1H, s, N1H), 8.91 (1H, 
s, N=CH), 8.45 (1H, s, CH
arom
), 8.14-8.06 (1H, d, CH
a-
rom
), 8.01-7.74 (2H, m, CH
arom
), 7.71-7.54 (1H, d, CH
a-
rom
), 7.39-7.16 (5H, m, CH
arom
), 5.58 (2H, s, N7-CH
2
), 
5.02 (2H, s, N3-CH
2






Yield 79.5  %. M.p. 277-279 °С. R
f









. Found, %: C, 53.49; H, 4.81; N, 24.20. 
Calculated, %: C, 53.79; H, 4.51; N, 23.90. IR-spec-
trum (ν, sm-1): 3310 (NH), 3150 (NH), 3035 (CH
arom
), 
1723 (C=O), 1680 (C=O), 1655 (C=N), 1595 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.67 (1H, s, CONH), 11.14 (1H, s, N1H), 7.88 (1H, 
s, N=CH), 7.42-7.10 (5H, m, CH
arom
), 5.41 (2H, s, N7-
CH
2
), 5.07 (2H, s, N3-CH
2






(3 -B e n z y l - 8 - m e t hy l x a n t h i ny l -7) - a c e -
tic acid (5-chloro-1-methyl-3-ethyl-1H-pyrazol-
4-ylmethylene)-hydrazide (5o)
Yield 74.7  %. M.p. 263-264 °С. R
f









. Found, %: C, 55.05; H, 5.10; N, 23.50. 
Calculated, %: C, 54.72; H, 4.80; N, 23.20. IR-spec-
trum (ν, sm-1): 3260 (NH), 3110 (NH), 3020 (CH
arom
), 
1710 (C=O), 1696 (C=O), 1633 (C=N), 1580 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.69 (1H, s, CONH), 11.11 (1H, s, N1H), 7.86 (1H, 
s, N=CH), 7.35-7.16 (5H, m, CH
arom
), 5.43 (2H, s, N7-
CH
2
), 5.05 (2H, s, N3-CH
2





), 2.32 (3H, s, C8-CH
3





Yield 76.3  %. M.p. 227-228 °С. R
f









. Found, %: C, 55.05; H, 4.31; N, 20.24. 
Calculated, %: C, 55.35; H, 4.01; N, 20.54. IR-spec-
trum (ν, sm-1): 3260 (NH), 3139 (NH), 3033 (CH
arom
), 
1700 (C=O), 1680 (C=O), 1660 (C=N), 1560 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.86 (1H, s, CONH), 11.14 (1H, s, N1H), 7.82 (1H, 
s, N=CH), 7.74 (1H, d, CH), 7.41-7.15 (5H, m, CH
a-
rom





), 5.06 (2H, s, N3-CH
2







Yield 71.5  %. M.p. 209-211 °С. R
f









. Found, %: C, 59.50; H, 4.31; N, 18.29. 
Calculated, %: C, 59.20; H, 4.01; N, 18.59. IR-spec-
trum (ν, sm-1): 3260 (NH), 3109 (NH), 3080 (CH
arom
), 
1713 (C=O), 1679 (C=O), 1658 (C=N), 1597 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 11.88 (1H, s, CONH), 11.15 (1H, s, N1H), 7.96 (1H, 
s, N=CH), 8.31-8.16 (2H, d, CH
arom
), 7.94-7.82 (2H, d, 
CH
arom
), 7.43-7.37 (1H, d, CH
arom
), 7.36-7.18 (5H, m, 
CH
arom
), 7.14-7.06 (1H, d, CH
arom
), 5.51 (2H, s, N7-
CH
2
), 5.07 (2H, s, N3-CH
2





Yield 92.3  %. M.p. >300 °С. R
f









. Found, %: C, 60.09; H, 3.89; N, 21.13. 
Calculated, %: C, 60.39; H, 4.19; N, 21.43. IR-spec-
trum (ν, sm-1): 3300 (NH), 3180 (NH), 3050 (CH
arom
), 
1720 (C=O), 1680 (C=O), 1660 (C=N), 1590 (C=C). 
1H NMR-spectrum (δ-scale, ppm., solvent DMSO-
d
6
): 12.72 (1H, s, NH), 11.32 (1H, s, CONH), 11.14 
(1H, s, N1H), 7.61-7.50 (1H, d, CH
arom
), 7.48-7.19 (6H, 
m, CH
arom
), 7.17-6.92 (1H, t, CH
arom
), 6.91-6.83 (1H, d, 
CH
arom
), 5.67 (2H, s, N7-CH
2
), 5.09 (2H, s, N3-CH
2
), 
2.36 (3H, s, C8-CH
3
).
Scripta Scientica Pharmaceutica, vol. 4, No. 1, 2017, pp. 39-45 
Medical University of Varna
43
Katherine Aleksandrova, Sergii Levich
(3-Benzyl-8-methylxanthinyl-7)-acetic acid 
[1-(4-amino-phenyl)-ethylidene]-hydrazide (5s)
Yield 69.8 %. M.p. >300 °С. R
f









Found, %: C, 64.47; H, 5.45; N, 19.22. Calculated, %: 
C, 64.17; H, 5.15; N, 19.52. IR-spectrum (ν, sm-1): 3250 
(NH), 3140 (NH), 3020 (CH
arom
), 1710 (C=O), 1692 
(C=O), 1649 (C=N), 1587 (C=C). 1H NMR-spectrum 
(δ-scale, ppm., solvent DMSO-d
6
): 11.12 (1H, s, N1H), 
10.75 (1H, s, CONH), 7.52-7.46 (2H, d, CH
arom
), 7.41-
7.14 (5H, m, CH
arom





), 5.51 (2H, s, N7-CH
2
), 5.11 (2H, s, N3-
CH
2
), 2.34 (3H, s, C8-CH
3
), 2.12 (3H, s, CH
3
).
RESULTS AND DISCUSSION 
In the previous works we have described the 
method of propyl 3-benzyl-8-methylxanthinyl-7-ac-
etate synthesis from 1-benzyl-5.6-diaminouracil 
(Fig. 1) (12).
In continuation of our search for potential bi-
ological active compounds among 3-beznylxanthine 
derivatives we obtained hydrazide of 3-beznylxan-
thinyl-7-acetic acid 4 by the reaction of ester 3 with 
hydrazine hydrate (Fig. 2). 
At 1Н  NMR-spectra of hydrazide 4 signals of 
methyl and methylene groups of ester residue were 
absent, but signals of hydrazide residue protons at 
9.37 ppm (1H, s) and 4.52 ppm (2H, w.s.) were pres-
ent. These and also intensive singlet of methylene 
group, that combined with a Nitrogen atom at posi-
tion 7, at 4.98 ppm proved the presence of acethydra-
zide residue in the structure of compound 4.
At the next stage we studied the reaction of hy-
drazide 4 with aliphatic, aromatic and heterocyclic 
carbonyl-containing compounds and obtained ap-
propriate ylidenehydrazides 5a-s (Fig. 3). Reaction 
was conducted by reflux of reagents in 50 % acetic 
acid or aqueous dioxane in the presence of catalytic 
amount of glacial acetic acid.
Ylidenehydrazides 5a-s are white, daffodil, yel-
low or orange crystal compounds, insoluble in wa-
Figure 1. Scheme of propyl 3-benzyl-8-methylxanthinyl-7-acetate synthesis
Figure 2. Scheme of hydrazide of 3-benzyl-8-methylxanthinyl-7-acetic acid synthesis
44
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ter, diethyl ether, soluble in DMSO, ethanol and 
propanol.
In IR-spectra of compounds 5a-s were present 
strips of absorption of N–H, C=O, C=C and C=N. 
In 1Н  NMR-spectra of ylidenehydrazides in 
comparison with initial hydrazide spectrum was ab-
sent signal of NН
2
-group. At the same time, singlets 
of methine groups protons (at interval 8.91-7.82 ppm) 
were registered. Protons of NН-group of hydrazide 
residue resonated at a more weak field at 12.08-11.49 
ppm. 
In the spectra of all ylidenehydrazides signals 
of appropriate ylidene residues protons were also 
registered. 
Thus, presence of 4-hydroxybenzylidene frag-
ment of the 1Н NMR-spectra of compound 5h was 
proved by singlet of ОН-group proton (at 9.89 ppm) 
and two doublets of protons of p-substituted ben-
zylidene residue (at 7.54-7.48 ppm and 6.85-6.72 
ppm). Substituents at 4 position of benzene ring of 
compounds 5b, 5g and 5i were proved by singlets of 
methyl at 2.28 ppm (compound 5b) and 2.94 ppm 
(compound 5g) and methoxy groups at 3.72 ppm 
(compound 5i).  
Synthesis of 3-benzyl-8-methylxanthinyl-
7-N’-[2-oxo-2,3-dihydro-1H-indol-3-ylidene]ace-
tohydrazide (compound 5r) was confirmed by the 
presence of a signal of NН-group of indole fragments 
at 12.72 ppm and increasing of the aromatic proton 
multiplet intensity up to 9. 
Figure 3. Scheme of ylidenhydrazides of 3-benzyl-8-methylxanthinyl-7-acetic acid synthesis
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CONCLUSIONS
The developed method could be used for hydra-
zides and ylidenhydrazides of 3-aralkylxanthinyl-
7-acetic acids synthesis. The PASS program progno-
sis confirmed that obtained compounds could have 
anti-bacterial and antifungal activities, which would 
be researched in further studies. 
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